Disrupted pulmonary vasculature and decreased vascular endothelial growth factor, Flt-1, and TIE-2 in human infants dying with bronchopulmonary dysplasia

American Journal of Respiratory and Critical Care Medicine

Volumn 164, Issue 10 I, 2001, Pages 1971-1980

  Bhatt, Abhay J ^a   Pryhuber, Gloria S ^a   Huyck, Heidie ^a   Watkins, Richard H ^a   Metlay, Leon A ^a   Maniscalco, William M ^a,b  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Lung development; Lung injury; Vasculogenesis

Indexed keywords

ANGIOGENIC FACTOR; CD31 ANTIGEN; MESSENGER RNA; TYROSINE KINASE RECEPTOR; TYROSINE KINASE RECEPTOR FLT 1; TYROSINE KINASE RECEPTOR TIE 2; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CAUSE OF DEATH; CONTROLLED STUDY; DYING; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; LUNG ALVEOLUS WALL; LUNG BLOOD VESSEL; LUNG CAPILLARY; LUNG DEVELOPMENT; LUNG DYSPLASIA; LUNG INJURY; OXYGEN THERAPY; PREMATURITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; VENTILATOR;

EID: 0035891595     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.164.10.2101140     Document Type: Article

References (38)

1. Morphometric analysis of the lung in bronchopulmonary dysplasia
2. Pathology of chronic lung disease in early infancy
3. Mechanisms initiating lung injury in the preterm
4. Fetal and postnatal development of the lung
5. Qualitative and quantitative analysis of embryonic pulmonary vessel formation
6. Diffuse alveolar damage in the evolution of bronchopulmonary dysplasia in the baboon
7. Neonatal chronic lung disease in extremely immature baboons
8. Vascular endothelial growth factor: Molecular and biological aspects
9. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
10. Expression of vascular endothelial growth factor and Flk-1 in developing and glucocorticoid-treated mouse lung
11. Hyperoxic injury decreases alveolar epithelial cell expression of vascular endothelial growth factor (VEGF) in neonatal rabbit lung
12. Vascular endothelial growth factor mRNA increases in alveolar epithelial cells during recovery from oxygen injury
13. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity
14. Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: Induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal
15. Extracellular cleavage of the vascular endothelial growth factor 189-amino acid form by urokinase is required for its mitogenic effect
16. Vascular endothelial growth factor inhibits endothelial cell apoptosis induced by tumor necrosis factor-alpha - Balance between growth and death signals
17. Vascular endothelial growth factor expression is decreased in rat lung following exposure to 24 or 48 hours of hyperoxia - Implications for endothelial cell survival
18. Role of the flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium
19. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice
20. Signaling vascular morphogenesis and maintenance
21. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis
22. Direct actions of angiopoietin-1 on human endothelium: Evidence for network stabilization, cell survival, and interaction with other angiogenic growth factors
23. Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia
24. Bronchopulmonary dysplasia: The pulmonary pathologic sequel of necrotizing bronchiolitis and pulmonary fibrosis
25. Bronchopulmonary dysplasia: A morphometric study with emphasis on the pulmonary vasculature
26. Ventilator-related pathology in the extremely immature lung
27. Induction of TNF receptor associated factor 1 (TRAF-1) in pulmonary epithelial cells by TNF-a and phorbol ester
28. Effect of prolonged exposure to 80% oxygen on the lung of the newborn mouse
29. Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation
30. In the human fetus, vascular endothelial growth factor is expressed in epithelial cells and myocytes, but not vascular endothelium: Implications for mode of action
31. Vascular endothelial growth factor is an essential molecule for mouse kidney development - Glomerulogenesis and nephrogenesis
32. VEGF and bFGF stimulate myocardial vascularization in embryonic chick
33. VEGF enhances pulmonary vasculogenesis and disrupts lung morphogenesis in vivo
34. Vascular endothelial growth factor in human preterm lung
35. Differential expression of VEGF mRNA splice variants in newborn and adult hyperoxic lung injury
36. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation
37. Vascular endothelial growth factor is expressed in ovine pulmonary vascular smooth muscle cells in vitro and regulated by hypoxia and dexamethasone
38. Corticosteroids inhibit the expression of the vascular endothelial growth factor gene in human vascular smooth muscle cells